In an interview with Pharmacy Times, Ali A. Habib, MD, clinical professor of neurology at the University of California, Irvine, discusses what the hospitalization findings mean for patients and why they should be viewed as supportive evidence
|Videos|May 29, 2014
Future Trends in Medication Adherence
Author(s)Davy James, Associate Editor
Jeremy Schafer, PharmD, MBA, Senior Director of Specialty Solutions and Manufacturer Relations at Prime Therapeutics, discusses new developments in medication adherence for specialty pharmacy.
Advertisement
Jeremy Schafer, PharmD, MBA, Senior Director of Specialty Solutions and Manufacturer Relations at Prime Therapeutics, discusses new developments in medication adherence for specialty pharmacy.
This video was shot at the Armada Health Care 2014 Specialty Pharmacy Summit and Expo in Las Vegas, Nevada.
Advertisement
Related to this article
The gap is not a paperwork inconvenience—it is a cash flow problem with clinical consequences.
Decades after cisplatin's approval, platinum-based chemotherapy continues to anchor treatment regimens across tumor types, new research finds.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Rising Gallbladder Complications With GLP-1 Receptor Agonists Call for Closer Pharmacist Monitoring
2
FDA Approves First Once-Monthly Subcutaneous Olanzapine LAI for Adults With Schizophrenia
3
Pneumonic Plague: What Pharmacists Need to Know About Treatment
4
FDA Approves Pritelivir for Refractory HSV Lesions in Immunocompromised Adults
5